Disease Severity Among Bio-Naive RA Patients on Csdmards

被引：0
|
作者：
Harrold, Leslie R. [1 ,2 ]
Griffith, Jenny [3 ]
Litman, Heather J. [2 ]
Feng, Hua [2 ]
Schlacher, Casey A. [3 ]
Kremer, Joel [4 ,5 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Corrona LLC, Waltham, MA USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Ctr Rheumatol, Albany, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
543
引用
收藏
页数：3
相关论文
共 50 条
  • [21] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    GASTROENTEROLOGY, 2023, 164 (04) : S47 - S47
  • [22] MINIMAL DISEASE ACTIVITY RESPONSE PATTERNS IN BIO-NAIVE PATIENTS TREATED WITH GUSELKUMAB: A MACHINE LEARNING ANALYSIS
    Zabotti, A.
    Ohrndorf, S.
    Tillett, W.
    Neuhold, M.
    van Speybroeck, M.
    Theander, E.
    Contre, C.
    Sharaf, M.
    Shawi, M.
    Perate, M.
    Kollmeier, A.
    Richette, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 171 - 171
  • [23] SERUM IL-10 AND IP-10 LEVELS IS AN IMPORTANT PREDICTOR OF RESPONSE TO TOCILIZUMAB IN BIO-NAIVE RA PATIENTS
    Kameda, T.
    Dobashi, H.
    Inoo, M.
    Onishi, I.
    Kurata, N.
    Susaki, K.
    Wakiya, R.
    Ozaki, H.
    Nakashima, S.
    Shimada, H.
    Takeuchi, Y.
    Izumikawa, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 439 - 439
  • [24] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S37 - S37
  • [25] DIRECT COMPARISON OF FOUR BIOLOGICAL AGENTS IN BIO-NAIVE RHEUMATOID ARTHRITIS PATIENTS
    Yonemoto, Y.
    Okamura, K.
    Takeuchi, K.
    Matsushita, M.
    Kaneko, T.
    Kobayashi, T.
    Aramaki, T.
    Takagishi, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 185 - 185
  • [26] Healthcare resource utilization following ustekinumab initiation among bio-naive Canadian patients with moderately-to-severely active Crohn's disease
    Bessissow, Talat
    Narula, Neeraj
    Ma, Christopher
    In, Tracy S. H.
    Pone, Eneda
    Eberg, Maria
    Jairath, Vipul
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (10) : 1690 - 1697
  • [27] Ustekinumab in bio-naive and bio-failure Crohn's disease patients: Results from a "real-life" monocentric cohort
    Monin, L.
    Dubois, S.
    Reenaers, C.
    Van Kemseke, C.
    Latour, P.
    Van Daele, D.
    Vieujean, S.
    Seidel, L.
    Louis, E.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (01) : 72 - 78
  • [28] REAL-WORLD LONG-TERM TREATMENT PERSISTENCE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE AND HISTORY OF FISTULA INITIATED ON USTEKINUMAB
    Zhdanava, Maryia
    Kachroo, Sumesh
    Boonmak, Porpong
    Burbage, Sabree
    Shah, Aditi
    Jiang, Zhuohan
    Lefebvre, Patrick
    Kerner, Caroline
    Pilon, Dominic
    GASTROENTEROLOGY, 2024, 166 (03) : S51 - S52
  • [29] REAL-WORLD LONG-TERM TREATMENT PERSISTENCE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE AND HISTORY OF FISTULA INITIATED ON USTEKINUMAB
    Zhdanava, Maryia
    Kachroo, Sumesh
    Boonmak, Porpong
    Burbage, Sabree
    Shah, Aditi
    Jiang, Zhuohan
    Lefebvre, Patrick
    Kerner, Caroline
    Pilon, Dominic
    INFLAMMATORY BOWEL DISEASES, 2024, 30
  • [30] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN BIO-NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE IN CANADA
    Bessissow, Talat
    Narula, Neeraj
    Ma, Christopher
    In, Tracy S.
    Eberg, Maria
    Karra, Kinda
    Belgnaoui, Mehdi
    Jairath, Vipul
    GASTROENTEROLOGY, 2022, 162 (07) : S811 - S811
12345